2024 Featured Speakers

Lynette M. Sholl, MD

Associate Professor of Pathology,
Brigham & Women's Hospital,
Boston, MA
A. James French Lecturer

Dr. Sholl obtained her MD from Stanford University School of Medicine. She completed a preliminary internship in internal medicine at the Hospital of the University of Pennsylvania before moving to Boston, MA to complete her AP residency at Brigham and Women's Hospital. While at BWH, she completed a fellowship in Molecular Genetic Pathology and served as the inaugural Joseph M. Corson Thoracic Pathology Fellow. After joining the BWH faculty in 2009, she assumed a role as Associate Director of the Center for Advanced Molecular Diagnostics (CAMD) and subsequently as Chief of the Thoracic Pathology service. Dr. Sholl has served as Medical Director of the CAMD since 2022 and as Vice Chair of Anatomic Pathology at BWH since 2023. Her research interests include the development of practical genomic and immunohistochemical biomarkers to guide the diagnosis and treatment of tumors of the lung, pleura, and thymus. She has served as an associate editor of Histopathology, as the subject editor at British Journal of Cancer, and the Senior Associate Editor at Journal of Molecular Diagnostics. She is active in the IASLC, USCAP, AMP and Pulmonary Pathology Society, where she is the current President. In her free time, Dr. Sholl enjoys chasing a PR in the half marathon and shouting from the sidelines at her kids' soccer and baseball games.

Annette Kim, MD, PhD

Henry Clay Bryant Professor of Pathology
Director, Division of Molecular and Genomic Pathology
Michigan Medicine
Plenary Lecturer

The Henry Clay Bryant Professor and Division Head of Diagnostic Genetics and Genomics at the University of Michigan, Annette S. Kim received her MD, PhD from Harvard in 1998. After a postdoc at Memorial Sloan Kettering Institute and several years at Merck, Dr. Kim completed her residency and fellowship in Hematopathology at the University of Pennsylvania in 2008. Dr. Kim has been the Medical Director at Cooper University Hospital (2008-2009) and hematopathologist and molecular pathologist at Vanderbilt University (2009-2015) and Brigham and Women’s Hospital (2015-2023). Dr. Kim’s research program has focused on the study of hematolymphoid malignancies, including miRNAs in myelodysplastic syndromes, myeloid and lymphoid mutational patterns, and test utilization management. At the Brigham and Women’s Hospital, Dr. Kim has served as the Laboratory Director of the Heme Molecular Lab and the Translational Biomarker Core of the Center for Advanced Molecular Diagnostics. She was Co-Director of the Interpretive Genomics Program at the Dana Farber Cancer Institute, the Director of the BH3 Profiling Laboratory, and the PI of the molecular core for the Leukemia SPORE program. She has served on several national pathology committees including the College of American Pathologists Molecular Oncology and Personalized Health Care Committees, the latter as current Vice-Chair, and the Association of Molecular Pathology Board and Executive Committee as well as chairing the Hematopathology Subdivision and the Training and Education Committees. In addition, she is the Vice-Chair of the ASH Precision Medicine committee, has served on the Somatic Working Group committee and currently serves on numerous other national biomarker and pathology committees. She has been awarded several teaching awards and was awarded the CAP Public Service Award in 2019.

Conference Organizers
		Jeffrey Myers, MD A. James French Professor of Diagnostic Pathology Professor, Thoracic Pathology University of Michigan Dr. Myers received a B.A. in Biology from Concordia College in Moorhead, Minnesota (1977), and an M.D. from Washington University School of Medicine, St. Louis, Missouri (1981) after completing his first two years of medical school training at the University of North Dakota. He completed residency training at Washington University, Barnes and Affiliated Hospitals from 1981-1984 where he also served as an American Cancer Society Regular Clinical Fellow. In 1985 he completed a fellowship in Surgical and Pulmonary Pathology at the University of Alabama at Birmingham and joined the faculty as an Assistant Professor of Pathology. In 1989, he accepted a position at the Mayo Clinic Minnesota where he was promoted to Associate Professor in 1991 and Professor in 1996. While at the Mayo Clinic, he served as Chair, Division of Anatomic Pathology (1993-2002) and Chair of the Clinical Practice Committee's Innovation Work Group (2003-2005). Dr. Myers joined the faculty of the Department of Pathology at the University of Michigan in January 2006 as the A. James French Professor of Diagnostic Pathology and Director, Division of Anatomic Pathology. In 2011 he was also appointed Director of MLabs. He serves as an Associate Director of the University of Michigan Medical Innovation Center. Dr. Myers has served as an invited speaker nationally and internationally on over 300 occasions and has over 200 publications in peer-reviewed scientific journals, abstracts, and book chapters. He is the recipient of numerous honors and awards including the Mayo Distinguished Clinician Award, the F.K. Mostofi Distinguished Service and President's Awards from the United States and Canadian Academy of Pathology, and the Outstanding Clinician Award from the University of Michigan Medical School. He is a member of a number of professional societies including the United States and Canadian Academy of Pathology, College of American Pathologists, American Society of Clinical Pathology, Arthur Purdy Stout Society, the American Thoracic Society, and the Michigan Society of Pathologists.

		Lauren Smith, MD Professor, Hematopathology University of Michigan Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years, she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at Michigan Medicine.

		Sara Abbott, MD Assistant Professor, Breast Pathology University of Michigan Dr. Sara Abbott is a surgical pathologist with an interest in women's health, particularly breast pathology. She received her undergraduate degree from Duke University. She later received her medical degree with special qualifications in biomedical research from Cleveland Clinic Lerner College of Medicine of Case Western Reserve University where she also obtained a master's degree in clinical research. She then completed her AP/CP residency and fellowship in breast and gynecologic pathology at Duke University in 2017. She also completed a second fellowship in Cancer Biomarker Pathology (with a focus in breast cancer biomarkers) at The University of Texas MD Anderson Cancer Center in 2018. She began her faculty career at Wake Forest Baptist Health before joining the Michigan Medicine Department of Pathology as an assistant professor in 2019. Her research interests include prognostic markers in breast cancer. She was awarded the International Society of Breast Pathology and Breast Cancer Research Foundation Award for Best Trainee Abstract in 2018 for her work on the role of ESR1 mutations in the development of endocrine therapy resistance in advanced breast cancer. She also has an interest in medical education, having completed a master's degree in teaching at Duke University and served as a national representative on the ACGME Pathology Residency Review Committee.

		Kyle Conway, MD, JD Assistant Professor, Neuropathology University of Michigan Kyle is from Crandon, Wisconsin, and attended medical school at the University of California, San Diego School of Medicine. Prior to medical school, he practiced law, including judicial clerkships with the Honorable David T. Prosser, Jr. on the Wisconsin Supreme Court and the Honorable Randolph W. Peterson on the Minnesota Court of Appeals. He is participating in the anatomic pathology/neuropathology track and is particularly interested in the combination of forensic pathology and neuropathology.

University of Michigan Speakers
	Eman Abdulfatah, MBBCh, MSc Assistant Professor	Ellen Chapel, MD Assistant Professor	Heather Chen-Yost, MD Instructor

	Julia Dahl, MD Assistant Professor	Margaret Fang, MD Assistant Professor	Sean Ferris, MD, PhD Assistant Professor

	Thomas Giordano, MD, PhD Henry Clay Bryant Professor	Mark Girton, MD Assistant Professor	Tao Huang, BM, PhD Assistant Professor

	Xiaobing Jin, MD, PhD Assistant Professor	Nora Joseph, MD Assistant Professor	Kristine Konopka, MD Associate Professor

	Richard Lieberman, MD Professor	Kamran Mirza, MBBS, PhD Godfrey D. Stobbe Professor	Kyle Perry, MD Associate Professor

	William Perry, MD Instructor	Jaclyn Plotzke, MD Fellow, Dermatopathology	Aaron Udager, MD, PhD Associate Professor

	Maria Westerhoff, MD Professor	Angela Wu, MD Associate Professor